Drug Discovery World

MAY 15, 2024

Dr Catherine Beech , CEO at Exonate and Dr Pete Adamson , CSO at Breye Therapeutics discuss the need for better therapies to treat diabetic retinal disease and current progress in the field. Specific numerical values (steps) denote the severity of NPDR, with 47-53 describing the moderately severe disease. orally administered compounds.

Disease 162

Disease Treatment Therapies Pharmaceuticals 162

Drug Discovery World

JANUARY 4, 2023

China is expected to record the highest diagnosed prevalence of non-alcoholic fatty liver disease (NAFLD) in 2029, representing 44% of cases within the 16 major pharmaceutical markets (16MM). According to GlobalData’s [.]. To read this content in full, you need to login.

Clinical Trials 130

Clinical Trials Trials Pharmaceutical Companies Pharmaceuticals 130

Drug Discovery World

JANUARY 9, 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. If approved , it would be the first in class as well as the first novel mechanism that has become available for maintenance COPD treatment in more than 10 years.

Drugs 173

Drugs Therapies Treatment Virus 173

Drug Discovery World

OCTOBER 4, 2022

This year’s event will cover some of the most exciting advancements in areas spanning screening, automation, high content imaging, disease models, cell and gene therapies and how innovation is being driven through partnerships and collaborations. In recent years sustainability has become more of a focus for the pharmaceutical industry.

Drugs 130

Drugs Therapies Clinical Trials Cell Based Assays 130

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). billion by 2029. It ensures regulatory compliance for over 15 long-term post-authorization safety studies across eight disease indications. from 2024 to reach US$129.8

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

Agency IQ

FEBRUARY 2, 2024

BY LAURA DIANGELO, MPH | JAN 30, 2024 10:25 AM CST Diagnostic regulation: A quick overview Diagnostics products are those intended to identify, signal or detect a specific health condition, infection or disease, or monitor a person’s health or health status. This is an extremely recent development, and an emerging area.

FDA 40

FDA Regulations Laboratories Production 40